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Early angiography after myocardial infarction: 
What have we learned? 
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Since the introduction of selective angiography in 
1959, by Sones and Shirey,’ a large body of knowl- 
edge of coronary anatomy in living humans has been 
accumulated. The relationship between angiograph- 
ic findings and stable or unstable angina pectoris or 
chronic myocardial infarction is well known. Until 
recently, because of the potential lethal complica- 
tions, angiography in acute myocardial infarction 
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(AMI) and early thereafter was not recommended; a 
waiting period of 2 to 3 months after the acute event 
was advised.* However, angiography early after 
infarction3e8 and even in the acute stage of AMIS-” 
has proved to be feasible and safe. Furthermore, 
acute angiography in evolving myocardial infarction 
is currently being used for applying fibrinolytic 
agents into the diseased coronary artery12-17 or for 
assessing coronary lesions preceding emergency cor- 
onary artery surgical revascularization.18 The knowl- 
edge which emerged from angiography after AM1 is 
considered in this article. 
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Table I. Frequency of total occlusion of infarct vessel in relation to time interval after onset of symptoms of AM1 
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relation to myocardial infarction in living humans 
was unknown. Most of our knnwledge had been 
derived from autopsy studies and thus involved a 
highly selective sample of the population studied. 
Angiography in the acute stages of myocardial 
infarction revealed that the rate of a complete 
coronary artery occlusion progressively declined as 
the time after onset of symptoms increased (Table 
I).3*7*8*11.15*1s-22 The frequency of a total occlusion 
within 6 hours after onset of symptoms is 80% to 
91%, at 6 to 24 hours 67%, at 2 weeks 53%, at 4 
weeks 45 % , at 6 to 8 weeks 47 % , at 4 to 6 months 
50%) and at 7 to 12 months 46 % . Although these 
findings provide no direct evidence for spontaneous 
recanalization, they strongly suggest that this may 
occur after infarction. Direct evidence for spontane- 
ous recanalization would require serial angiograms 
in the same person. 
Spontaneous recanalization, probably as a conse- 
quence of endogenous thrombolysis, apparently 
occurs only in the first hours and weeks after AM1 
and levels off after 2 weeks. Whatever complex 
pathogenetic processes are involved, the onset of a 
transmural myocardial infarction is associated with 
total coronary artery obstruction, which apparently 
is transient in many patients. From recent experi- 
ence with intracoronary streptokinase it appears 
that an occlusive thrombus, which can be dissolved 
in +80% of patients, plays a major role in the 
process.23 Wackers et al.24 demonstrated spontane- 
ous improvement in left ventricular ejection fraction 
within the first 24 hours after transmural AMI. This 
improvement may be associated with spontaneous 
recanalization, as has been suggested by Ong et al.25 
They studied 52 patients with AM1 not treated with 
thrombolytic agents. They found that spontaneous 
recanalization, as evidenced by rapid release of 
CK-MB, was associated with spontaneous improve- 
ment of left ventricular function. de Feijter et aLz6 
demonstrated better left ventricular function in 
patients with spontaneous recanalization than with 
persisting occlusion of the infarct vessel in patients 
with a first transmural AMI, who were catheterized 
6 to 8 weeks after the acute event. These findings 
may have an important bearing upon the evaluation 
of the technique of intracoronary fibrinolytic treat- 
ment and stress the necessity of randomized 
studies. 
Extent of coronary artery disease in survivors of AMI. 
As coronary angiography has not been routinely 
performed in patients who are asymptomatic after 
infarction, most studies tend to be biased toward 
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Table II. Extent of coronary disease in survivors of AM1 
Reference 







(SO of total) 
Catheterization 
after acute eoent 
Bertrand et al.’ 
Taylor et aLO 
Turner et al.s 
Betriu et aLR 
de Feyter et al.’ 
Gibson et al.*’ 
Roubin et al.2” 
106 50.4 k 8.6 7 7 ? 16.0 k 3 days 
106 48.6 f 9.9 26 39 26 12.5 A 1.6 days 
92 54 2 1 13 70 27 22 k 1 days 
259 57.3 z!z 5 0 91 9 <30 days 
179 .52 ? 5 10 81 8 <6-8 wk 
140 51 i 8 1 3 72 19 Before discharge 
229 c51 15 89 11 IO days-16 wk 
*Significant coronary lesion was defined as an obstruction X0!” of the luminal diameter in all studies except those of Turner et al.’ and Rouhin et al.28 
(>70’~ ); left main disease was considered as two-vessel disease (circumflex and left anterior descending). 
W-vessel disease: totally normal or a lesion less than 50r0 luminal diameter. 
Table IV. Prevalence of multivessel disease in survivors of transmural and nontransmural myocardial infarction 
Transmural Nontransmural 
-___ 
No. of Multivessel disease No. of Multivessel disease 
Reference patients Oh patients T 
Taylor et akO 64 12 42 76 
Turner et al.‘* 34 76 23 74 
de Feyter et al.’ 143 .54 21 48 
Roubin et ak2* 148 37 78 32 
*Also included patients with catheterization later than 22 f 1 days after acute event (18’,, had angiography after 30 days: mean 64 + 7). 












Bertrand et al3 45 71 61 79 
Taylor et aLb 29 59 35 83 
de Feyter et al.’ 62 41 81 73 
Roubin et aLz8 114 31 108 39 
Table VI. Prevalence of multivessel disease in survivors of AM1 with early postinfarction angina pectoris (within 8 
weeks after acute event) 
Postinfarction angina 
Postinfarction angina absent 
No. of Multivessel disease No. of Multivessel disease 
Reference patients 5 patients 0; 
Turner et aL5* 26 92 91 70 
de Feyter et al.’ 52 79 127 45 
*Included are patients with catheterization later than 22 k 1 days after the acute event (lSOS had angiography after 30 days: 64 f 7). 
high-risk patients. Thus, much of our knowledge of postinfarct patients or complicated transfers from 
coronary anatomy is derived from referred symp- other hospitals, in an attempt to simulate the 
tomatic patients. In this article we present only data patient population with AMI seen in a community 
from those prospective studies2 5-7, 27,28 in which hospital. The study of Madigan et alTs was rejected 
patient intake was not biased toward symptomatic because of its apparent bias toward high-risk 
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patients. In their study of 50 survivors of subendo- 
cardial infarction, 60% had multivessel disease, but 
80% were catheterized for angina, which was unsta- 
ble in 66%. 
Only a few prospective angiographic studies after 
AM1 have been performed, which give insight into 
the overall spectrum of coronary lesions associated 
with the infarction. The results of these studies vary, 
depending mainly on the selection criteria and the 
eligibility. In Table II the extent of coronary artery 
disease is presented in survivors of AMI. All patients 
were less than 70 years of age. Coronary angiography 
was performed 4 to 8 weeks after the acute event. 
Normal vessels or minimal lesions were present in 
0% to 7%) one-vessel disease was present in 23% to 
58 % , two-vessel disease in 21% to 45 % , and three- 
vessel disease in 10% to 53 % . The prevalence of left 
main stem artery disease varied from 1% to 11% 
(Table III). The higher prevalence of left main 
disease (11%) in the studies of Turner et aL5 and 
Taylor et a1.6 compared to the other studies’*8*27~28 
may be caused by patient selection. Both studies 
had a higher prevalence of previous AM1 (which is 
associated with a higher prevalence of multivessel 
disease) and a lower percentage of eligibility. The 
prevalence of multivessel disease did not differ in 
patients with a transmural or nontransmural AM1 
(Table IV). In transmural AM1 multivessel disease 
was present in 37 % to 76 % and in nontransmural 
AM1 this was 32 % to 76%. The prevalence of 
multivessel disease is significantly (p < 0.001, Man- 
tel-Hoenszel test) higher in survivors of a transmu- 
ral inferior wall AM1 than in survivors of a transmu- 
ral anterior wall AM1 (Table V). The prevalence of 
multivessel disease is significantly (p < 0.001) high- 
er in patients with early postinfarction angina pecto- 
ris (79% to 92% ) than in those without angina 
pectoris (45% to 70%) (Table VI). Finally, in 
patients with a previous AM1 the presence of multi- 
vessel disease was higher (73 % to 100 % ) than in 
Table Ill. Prevalence of left main stem coronary artery 
disease in survivors of myocardial infarction 
References 
Taylor et al.’ 
Turner et al.’ 
Betriu et al.* 
de Feyter et al.’ 
Gibson et al.” 


















patients with a first infarction (31% to 64% ) (Ta- 
ble VII). 
Left ventricular dysfunction in survivors of AMI. What 
is the extent of left ventricular damage caused by 
AM1 in a nonselected population? An ejection frac- 
tion less than 30 % was present in 7 % to 17 % of the 
patients, an ejection fraction of 30% to 49% was 
found in 44% to 55%) and an ejection fraction of 
50% or more was present in 31% to 48% (Table 
VIII). Similar data were found with radionuclide 
determined ejection fractions.27 
The ejection fraction was significantly lower in 
patients with multivessel disease than in those with 
single-vessel disease. 7,8 In patients with a total 
occlusion of the infarct vessel the ejection fraction 
was lower and the impairment of left ventricular 
wall motion was higher than in those with a lesser 
degree of obstruction of the infarct vessel.sj26 Left 
ventricular damage was more severe with anterior 
wall myocardial infarction than with inferior wall 
myocardial infarction. 6-*,26 A severely depressed left 
ventricular function was found in patients with 
previous myocardial infarction. Apparently, a well- 
developed collateral circulation improved the ejec- 
tion fraction and decreased the size of akinetic 
segments.8* 3o 
Prognostic value of angiography and ventriculogra- 
phy soon after AMI. In patients younger than 65 years, 
the value of angiography and ventriculography as 
determinants of prognosis after infarction has been 
investigated. 6,7,28,31 Sanz et aL31 found that the ejec- 
tion fraction and the number of diseased vessels 
were the only independent invasive predictors of 
survival during a follow-up study of 60 months. 
Patients with a normal ejection fraction, regardless 
of the number of diseased vessels, lived longest. The 
probability of survival of patients with an ejection 
fraction of 21% to 49% ranged from 78% for 
patients with three-vessel disease to 95% for those 
with single-vessel disease. The poorest prognosis 
198 de Feyter et al. 
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Table VII. Prevalence of multivessel disease in patients with and without previous myocardial infarction 
Previous myocardial infarction 
Reference 
Taylor et al? 
Betriu et al.* 
de Feyter et al.’ 



























Table VIII. Left ventricular function in survivors of AM1 
Ejection fraction 
Reference No. of patients 
Taylor et al.” 106 
Betriu et al.s 259 
de Feyter et al.’ 179 
Roubin et al.Z8 229 
<30x? 




SO-50 % >50% 





*Ejection fraction <49”n 
corresponded to an ejection fraction less than 20%: 
30% to 75% depending on the number of diseased 
vessels. According to the 30-month follow-up study 
of Taylor et al.,6 univariate analysis showed that low 
ejection fraction, proximal left anterior descending 
coronary artery disease, and three-vessel disease 
were associated with a high risk of sudden cardiac 
death. However, multivariate analysis of 30 clinical 
and laboratory variables identified previous myocar- 
dial infarction and an ejection fraction less than 
40% as predictors of death. Additional information 
was not provided by the other variables once these 
two variables were considered. According to de 
Feyter et al.,7 patients with an ejection fraction less 
than 30% and three-vessel disease formed a high- 
risk group for cardiac death. During a mean follow- 
up of 28 months, 10 of the 11 cardiac deaths 
occurred in this high-risk group. 
Roubin et al.% showed that three-vessel disease 
had a lower survival rate at 1 year than two- and 
one-vessel disease. Also, although not at a signifi- 
cant level, an ejection fraction lower than 50% was 
associated with a lower l-year survival rate. Thus, it 
appears that cardiac death in survivors of AM1 is 
related to the extent of coronary artery disease and 
the severity of left ventricular dysfunction. 
Angiography in all survivors of AMI? Cardiac cathe- 
terization can be performed relatively safely early 
after a sustained myocardial infarction. Of a total of 
486 patients who underwent angiography, there 
were no procedure-related deaths and major compli- 
cations occurred in 1% to 3% .3*5-7 Should we then 
proceed to perform coronary angiography before 
discharge in all patients after myocardial infarction 
in an attempt to guide therapy to assess progno- 
sis? 
Certainly, patients recovering from AMI, who are 
symptomatic, should be appropriately evaluated; 
this may include coronary angiography and left 
ventriculography. However, is there a need for angi- 
ography in asymptomatic postinfarction patients? 
Two recent studies32,33 have shown that surgery is 
not superior to medical treatment for improving 
survival rates in asymptomatic postinfarction 
patients. On the other hand, to assess prognosis and 
to identify high-risk patients clinical variables or 
noninvasive tests such as exercise ECGs and radio- 
nuclide studies appear to be appropriate and only 
those with evidence of inducible ischemia should 
undergo cardiac catheterization.34 Therefore, coro- 
nary angiography is reserved only for symptomatic 
patients not responding adequately to optimal med- 
ical treatment in order to assess operability. 
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